TalkMed Shareholders Approve Privatization by Tamarind Health

TigerNews SG

07-16

TalkMed shareholders on Tuesday (Jul 15) overwhelmingly approved a privatization offer from Tamarind Health, with 98 shareholders (89.1% of those present) voting in favor. The resolution, backed by holders of 1.2 billion shares (99.9% of votes cast), paves the way for the company’s delisting at S$0.456 per share.

The deal, proposed by Tamarind-managed TW Troy on Dec 23, 2024, received regulatory clearance from Singapore’s Competition and Consumer Commission on Jun 27. Following shareholder approval, TalkMed will now seek court sanction for the scheme, with a hearing expected around Aug 5.

Trading of TalkMed shares is set to cease around Aug 8, with books closing on Aug 19. If court approval is granted and conditions met, the scheme will take effect on Aug 20, with payment to shareholders due by Aug 29 ahead of delisting by Sep 2.

The company also requested a lift of its trading halt on Tuesday evening. Its shares last traded at S$0.455.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1196067473"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1196067473\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1196067473?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-16 14:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1196067473","market":"sg","top_or_hot":-1,"title":"TalkMed Shareholders Approve Privatization by Tamarind Health","media":"TigerNews SG","content":"<p>TalkMed shareholders on Tuesday (Jul 15) overwhelmingly approved a privatization offer from Tamarind Health, with 98 shareholders (89.1% of those present) voting in favor. The resolution, backed by holders of 1.2 billion shares (99.9% of votes cast), paves the way for the company’s delisting at S$0.456 per share.</p><p style=\"text-align: start;\">The deal, proposed by Tamarind-managed TW Troy on Dec 23, 2024, received regulatory clearance from Singapore’s Competition and Consumer Commission on Jun 27. Following shareholder approval, TalkMed will now seek court sanction for the scheme, with a hearing expected around Aug 5.</p><p style=\"text-align: start;\">Trading of TalkMed shares is set to cease around Aug 8, with books closing on Aug 19. If court approval is granted and conditions met, the scheme will take effect on Aug 20, with payment to shareholders due by Aug 29 ahead of delisting by Sep 2.</p><p style=\"text-align: start;\">The company also requested a lift of its trading halt on Tuesday evening. Its shares last traded at S$0.455.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TalkMed Shareholders Approve Privatization by Tamarind Health</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTalkMed Shareholders Approve Privatization by Tamarind Health\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1050470178\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/f17a9a7b68c877792d5e556261e9e709);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">TigerNews SG </p>\n<p class=\"h-time smaller\">2025-07-16 14:44</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>TalkMed shareholders on Tuesday (Jul 15) overwhelmingly approved a privatization offer from Tamarind Health, with 98 shareholders (89.1% of those present) voting in favor. The resolution, backed by holders of 1.2 billion shares (99.9% of votes cast), paves the way for the company’s delisting at S$0.456 per share.</p><p style=\"text-align: start;\">The deal, proposed by Tamarind-managed TW Troy on Dec 23, 2024, received regulatory clearance from Singapore’s Competition and Consumer Commission on Jun 27. Following shareholder approval, TalkMed will now seek court sanction for the scheme, with a hearing expected around Aug 5.</p><p style=\"text-align: start;\">Trading of TalkMed shares is set to cease around Aug 8, with books closing on Aug 19. If court approval is granted and conditions met, the scheme will take effect on Aug 20, with payment to shareholders due by Aug 29 ahead of delisting by Sep 2.</p><p style=\"text-align: start;\">The company also requested a lift of its trading halt on Tuesday evening. Its shares last traded at S$0.455.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"5G3.SI","symbol_name":"TALKMED集團","start_time":0,"source_url":"","article_id":"1196067473","we_media_id":"1050470178","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1196067473","pubTimestamp":1752648299,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"TigerNews SG","introduction":"Providing stock market headlines, business news, financials and earnings","home_visible":1,"id":"1050470178","head_image":"https://community-static.tradeup.com/news/f17a9a7b68c877792d5e556261e9e709"},"summary":"TalkMed shareholders on Tuesday (Jul 15) overwhelmingly approved a privatization offer from Tamarind Health, with 98 shareholders (89.1% of those present) voting in favor. The resolution, backed by...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"5G3.SI":"TALKMED集团"},"translate_title":"TalkMed股东批准Tamarind Health私有化","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"5G3.SI":1.1},"content_text":"TalkMed shareholders on Tuesday (Jul 15) overwhelmingly approved a privatization offer from Tamarind Health, with 98 shareholders (89.1% of those present) voting in favor. The resolution, backed by holders of 1.2 billion shares (99.9% of votes cast), paves the way for the company’s delisting at S$0.456 per share.The deal, proposed by Tamarind-managed TW Troy on Dec 23, 2024, received regulatory clearance from Singapore’s Competition and Consumer Commission on Jun 27. Following shareholder approval, TalkMed will now seek court sanction for the scheme, with a hearing expected around Aug 5.Trading of TalkMed shares is set to cease around Aug 8, with books closing on Aug 19. If court approval is granted and conditions met, the scheme will take effect on Aug 20, with payment to shareholders due by Aug 29 ahead of delisting by Sep 2.The company also requested a lift of its trading halt on Tuesday evening. Its shares last traded at S$0.455.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}